"Cell Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.
| Descriptor ID |
D060846
|
| MeSH Number(s) |
E05.481.500.311 J01.293.069.249
|
| Concept/Terms |
Cell Engineering- Cell Engineering
- Engineering, Cell
- Cellular Engineering
- Engineering, Cellular
|
Below are MeSH descriptors whose meaning is more general than "Cell Engineering".
Below are MeSH descriptors whose meaning is more specific than "Cell Engineering".
This graph shows the total number of publications written about "Cell Engineering" by people in this website by year, and whether "Cell Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 3 | 2 | 5 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 2 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2020 | 3 | 1 | 4 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Engineering" by people in Profiles.
-
Splendid isolation. Blood. 2023 06 01; 141(22):2665-2666.
-
Engineered Cytokine Signaling to Improve CAR T Cell Effector Function. Front Immunol. 2021; 12:684642.
-
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells. Front Immunol. 2021; 12:626098.
-
Transgenic CD8a? co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells. J Immunother Cancer. 2020 11; 8(2).
-
Emerging role of bacterial extracellular vesicles in cancer. Oncogene. 2020 11; 39(46):6951-6960.
-
Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021 01; 39(1):56-63.
-
Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineering. PLoS One. 2020; 15(2):e0228112.
-
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities. Expert Opin Biol Ther. 2018 06; 18(6):653-664.
-
Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo. Nat Commun. 2018 04 10; 9(1):1325.
-
Efficacy of intracellular immune checkpoint-silenced DC vaccine. JCI Insight. 2018 02 08; 3(3).